[{"Assets_0_Q3_USD":12618745000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":260877000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":259707000.0,"StockholdersEquity_0_Q3_USD":9530708000.0,"RevenuesConverted_3_Q3_USD":5501839000.0,"RevenuesConverted_1_Q3_USD":1984164000.0,"NetIncomeLossConverted_3_Q3_USD":1571990000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":257876000.0,"NetIncomeLossConverted_1_Q3_USD":851928000.0,"EarningsPerShareDiluted_3_Q3_USD":6.03,"EarningsPerShareDiluted_1_Q3_USD":3.28,"EarningsPerShareBasic_3_Q3_USD":6.08,"EarningsPerShareBasic_1_Q3_USD":3.3,"CommonStockSharesOutstanding_0_Q3_shares":256206000.0,"CommonStockSharesConverted_0_Q3_shares":256206000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":1648507000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":258740000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20211103"}]